Does TOFACITINIB Cause Post procedural infection? 184 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 184 reports of Post procedural infection have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
184
Reports of Post procedural infection with TOFACITINIB
0.1%
of all TOFACITINIB reports
2
Deaths
73
Hospitalizations
How Dangerous Is Post procedural infection From TOFACITINIB?
Of the 184 reports, 2 (1.1%) resulted in death, 73 (39.7%) required hospitalization, and 3 (1.6%) were considered life-threatening.
Is Post procedural infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 184 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Post procedural infection?
ADALIMUMAB (1,109)
ETANERCEPT (362)
METHOTREXATE (226)
INFLIXIMAB (223)
UPADACITINIB (188)
GOLIMUMAB (177)
VEDOLIZUMAB (166)
RISANKIZUMAB-RZAA (157)
USTEKINUMAB (150)
ABATACEPT (136)
Which TOFACITINIB Alternatives Have Lower Post procedural infection Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN